OTCM (OTC Markets Group) Research & Development: $0.0 Mil (TTM As of Mar. 2026)


OTCM OTC Markets Group Inc OTCM
89 GF Score
Price $51.03
GF Value $60.84
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is OTC Markets Group Research & Development?

OTC Markets Group OTCM -0.87% 89 Research & Development is $0.0 Mil as of Mar. 2026. GuruFocus rates OTCM with a GF Score™ of 89/100 and a GF Value™ of $60.84 (Modestly Undervalued). The stock has 2 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. OTC Markets Group's Research & Development for the three months ended in Mar. 2026 was $0.0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was $0.0 Mil.

OTC Markets Group  (OTCPK:OTCM) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

OTC Markets Group Research & Development Related Terms

OTC Markets Group Research & Development Historical Data

* Premium members only.

The historical data trend for OTC Markets Group's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

OTC Markets Group Research & Development Chart

OTC Markets Group Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

OTC Markets Group Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
OTCM
89GF Score
OTC Markets Group Inc OTCM
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

OTC Markets Group Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $0.0 Mil mean?
OTC Markets Group (OTCM) has a Research & Development of $0.0 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on OTC Markets Group and its competitors.
Is OTC Markets Group's Research & Development too high?
OTC Markets Group's current Research & Development is $0.0 Mil. Overall, OTC Markets Group has a GF Score™ of 89/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does OTC Markets Group's Research & Development compare to VALU and DTCX?
OTC Markets Group's Research & Development of $0.0 Mil can be compared against companies in the Capital Markets industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Capital Markets company?
A good Research & Development depends on the Capital Markets industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on OTC Markets Group and its competitors. OTC Markets Group's current Research & Development is $0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is OTC Markets Group stock overvalued right now?
Based on GuruFocus' analysis, OTC Markets Group (OTCM) is currently considered Modestly Undervalued. The stock's GF Value™ is $60.84, compared to a current price of $51.03 — trading 16.1% below its estimated fair value. The current Research & Development is $0.0 Mil. OTC Markets Group's overall GF Score™ is 89/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For OTC Markets Group (OTCM), the current Research & Development is $0.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is OTC Markets Group (OTCM) Overvalued in 2026?

Based on GuruFocus' analysis, OTC Markets Group stock appears to be undervalued. The current stock price of $51.03 is trading 16.1% below its estimated GF Value™ of $60.84. GuruFocus considers OTC Markets Group to be Modestly Undervalued.

Key valuation signals for OTCM:

  • Research & Development: $0.0 Mil
  • GF Value™: $60.84 vs. price of $51.03 (16.1% below fair value)
  • GF Score™: 89/100 with 2 warning signs

No single metric tells the full story. See the OTCM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

OTC Markets Group Business Description

Address 300 Vesey Street, New York, NY, USA, 10282
OTC Markets Group Inc operates financial markets for securities in the U.S. and globally. The firm mainly operates OTCQX market, OTCQB venture market and Pink open market. It has OTC link ATS, market data licensing and corporate services business lines. The activities of these business lines encompass quotation and trade messaging services, network-based platform, access to market data, a suite of market data licenses and disclosure and information services. It derives a majority of its revenue from the U.S.
89GF Score

Get the complete analysis for OTCM

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$51.03
Price
$60.84
GF Value